120 related articles for article (PubMed ID: 14528105)
21. Metastatic osteosarcoma and multiple lung resection. A case report.
Blasier D; Mayba I; Ferguson C; DeSa D; Bishop A; Letts M
J Bone Joint Surg Br; 1986 Nov; 68(5):748-50. PubMed ID: 3465733
[TBL] [Abstract][Full Text] [Related]
22. Multiple relapses in high-grade osteosarcoma: when to stop aggressive therapy?
Tamamyan G; Dominkus M; Lang S; Diakos C; Mittheisz E; Horcher E; Holter W; Zoubek A; Bielack S; Kager L
Pediatr Blood Cancer; 2015 Mar; 62(3):529-30. PubMed ID: 25611048
[TBL] [Abstract][Full Text] [Related]
23. Neoadjuvant chemotherapy for osteosarcoma of the extremities in preadolescent patients: the Rizzoli Institute experience.
Bacci G; Balladelli A; Palmerini E; Alberghini M; Pollastri P; Galletti S; Mercuri M; Picci P
J Pediatr Hematol Oncol; 2008 Dec; 30(12):908-12. PubMed ID: 19131777
[TBL] [Abstract][Full Text] [Related]
24. Combined modality treatment for osteosarcoma occurring as a second malignant disease. Cooperative German-Austrian-Swiss Osteosarcoma Study Group.
Bielack SS; Kempf-Bielack B; Heise U; Schwenzer D; Winkler K
J Clin Oncol; 1999 Apr; 17(4):1164. PubMed ID: 10561175
[TBL] [Abstract][Full Text] [Related]
25. Prognostic factors in elderly osteosarcoma patients: a multi-institutional retrospective study of 86 cases.
Iwata S; Ishii T; Kawai A; Hiruma T; Yonemoto T; Kamoda H; Asano N; Takeyama M
Ann Surg Oncol; 2014 Jan; 21(1):263-8. PubMed ID: 23975321
[TBL] [Abstract][Full Text] [Related]
26. Primary metastatic osteosarcoma: presentation and outcome of patients treated on neoadjuvant Cooperative Osteosarcoma Study Group protocols.
Kager L; Zoubek A; Pötschger U; Kastner U; Flege S; Kempf-Bielack B; Branscheid D; Kotz R; Salzer-Kuntschik M; Winkelmann W; Jundt G; Kabisch H; Reichardt P; Jürgens H; Gadner H; Bielack SS;
J Clin Oncol; 2003 May; 21(10):2011-8. PubMed ID: 12743156
[TBL] [Abstract][Full Text] [Related]
27. Experience of pediatric osteosarcoma of the extremity at a single institution in Taiwan: prognostic factors and impact on survival.
Hung GY; Yen HJ; Yen CC; Chen WM; Chen PC; Wu HT; Chiou HJ; Chang WH; Hsu HE
Ann Surg Oncol; 2015 Apr; 22(4):1080-7. PubMed ID: 25323470
[TBL] [Abstract][Full Text] [Related]
28. Neoadjuvant chemotherapy for osteosarcoma of the extremities with synchronous lung metastases: treatment with cisplatin, adriamycin and high dose of methotrexate and ifosfamide.
Bacci G; Briccoli A; Ferrari S; Saeter G; Donati D; Longhi A; Manfrini M; Bertoni F; Rimondini S; Monti C; Forni C
Oncol Rep; 2000; 7(2):339-46. PubMed ID: 10671683
[TBL] [Abstract][Full Text] [Related]
29. Pathological fractures in predicting clinical outcomes for patients with osteosarcoma.
Chung LH; Wu PK; Chen CF; Weng HK; Chen TH; Chen WM
BMC Musculoskelet Disord; 2016 Dec; 17(1):503. PubMed ID: 28031047
[TBL] [Abstract][Full Text] [Related]
30. Review of management issues in relapsed osteosarcoma.
Vijayamurugan N; Bakhshi S
Expert Rev Anticancer Ther; 2014 Feb; 14(2):151-61. PubMed ID: 24308680
[TBL] [Abstract][Full Text] [Related]
31. Pathologic fracture does not influence local recurrence and survival in high-grade extremity osteosarcoma with adequate surgical margins.
Xie L; Guo W; Li Y; Ji T; Sun X
J Surg Oncol; 2012 Dec; 106(7):820-5. PubMed ID: 22740310
[TBL] [Abstract][Full Text] [Related]
32. Osteosarcoma relapse after combined modality therapy: an analysis of unselected patients in the Cooperative Osteosarcoma Study Group (COSS).
Kempf-Bielack B; Bielack SS; Jürgens H; Branscheid D; Berdel WE; Exner GU; Göbel U; Helmke K; Jundt G; Kabisch H; Kevric M; Klingebiel T; Kotz R; Maas R; Schwarz R; Semik M; Treuner J; Zoubek A; Winkler K
J Clin Oncol; 2005 Jan; 23(3):559-68. PubMed ID: 15659502
[TBL] [Abstract][Full Text] [Related]
33. Survival after second and subsequent recurrences in osteosarcoma: a retrospective multicenter analysis.
Tirtei E; Asaftei SD; Manicone R; Cesari M; Paioli A; Rocca M; Ferrari S; Fagioli F
Tumori; 2018 Jun; 104(3):202-206. PubMed ID: 30086698
[TBL] [Abstract][Full Text] [Related]
34. The prognosis of patients with primary osteosarcoma who have undergone unplanned therapy.
Wang TI; Wu PK; Chen CF; Chen WM; Yen CC; Hung GY; Liu CL; Chen TH
Jpn J Clin Oncol; 2011 Nov; 41(11):1244-50. PubMed ID: 21994209
[TBL] [Abstract][Full Text] [Related]
35. Treatment algorithm for locally recurrent osteosarcoma based on local disease-free interval and the presence of lung metastasis.
Nathan SS; Gorlick R; Bukata S; Chou A; Morris CD; Boland PJ; Huvos AG; Meyers PA; Healey JH
Cancer; 2006 Oct; 107(7):1607-16. PubMed ID: 16933325
[TBL] [Abstract][Full Text] [Related]
36. Metastatic osteosarcoma at diagnosis: prognostic factors and long-term outcome--the French pediatric experience.
Mialou V; Philip T; Kalifa C; Perol D; Gentet JC; Marec-Berard P; Pacquement H; Chastagner P; Defaschelles AS; Hartmann O
Cancer; 2005 Sep; 104(5):1100-9. PubMed ID: 16015627
[TBL] [Abstract][Full Text] [Related]
37. Pediatric Chondromyxoid Fibroma-Like Osteosarcoma.
Stark M; Heinrich SD; Sivashanmugam R; Mackey D; Wasilewska E; Craver R
Fetal Pediatr Pathol; 2017 Apr; 36(2):154-161. PubMed ID: 27935335
[TBL] [Abstract][Full Text] [Related]
38. Osteosarcoma of the pelvis: outcome analysis of surgical treatment.
Fuchs B; Hoekzema N; Larson DR; Inwards CY; Sim FH
Clin Orthop Relat Res; 2009 Feb; 467(2):510-8. PubMed ID: 18855090
[TBL] [Abstract][Full Text] [Related]
39. What is the best clinical approach to recurrent/refractory osteosarcoma?
Meazza C; Bastoni S; Scanagatta P
Expert Rev Anticancer Ther; 2020 May; 20(5):415-428. PubMed ID: 32379504
[No Abstract] [Full Text] [Related]
40. Metastatic patterns in osteosarcoma.
Bacci G; Avella M; Picci P; Briccoli A; Dallari D; Campanacci M
Tumori; 1988 Aug; 74(4):421-7. PubMed ID: 3055577
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
